Yogesh Patel
Cardiovascular Disease · Rolla, MONPI 1235157876
Payments from drug & device makers
Across 92 payments — averaging $35.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$270
- Johnson & Johnson$233
- Boston Scientific$134
- Medtronic$128
- Vifor Pharma, Inc.$107
- plus $746 from 18 others
What the payments were for
- Travel & lodging$1,28739%
- Food & beverage$2,01161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 8 | $1,680 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $270 |
| Johnson & Johnson | 20 | $233 |
| Boston Scientific | 5 | $134 |
| Medtronic | 1 | $128 |
| Vifor Pharma, Inc. | 6 | $107 |
| Amgen | 5 | $88 |
| Chiesi USA, Inc. | 2 | $86 |
| Novartis | 6 | $86 |
| AstraZeneca | 5 | $80 |
| Braemar Manufacturing, LLC | 1 | $59 |
| Shockwave Medical, Inc | 1 | $55 |
| Spinal Simplicity, LLC | 2 | $45 |
| Amarin Pharma, Inc. | 2 | $37 |
| Abbott | 1 | $30 |
| Boehringer Ingelheim | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Getinge USA Sales, LLC | 1 | $24 |
| Cardiovascular Systems Inc. | 1 | $23 |
| Edwards Lifesciences | 1 | $22 |
| Gilead | 1 | $15 |
| Merck | 1 | $14 |
| Vistapharm, Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,298 in reported general payments places this provider in the 55th percentile of 391 cardiovascular disease providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 19 | $319 |
| Metoprolol Succinate | 17 | $271 |
| Atorvastatin Calcium | 12 | $56 |
| Lisinopril | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Rolla
- Mikhail KosiborodKansas City$27.8M
- Mohammad TahirSaint Louis$2.7M
- John SpertusKansas City$2.3M
- Joshua MitchellSaint Louis$1.4M
- Nathan StitzielSaint Louis$1.2M
- Daniel KellySaint Louis$1.1M
- Georges ChahoudSaint Louis$967K
- Jiafu OuSaint Louis$853K
- William BowenSaint Louis$726K
- Omar AlmousalliFestus$690K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.